<bill session="117" type="h" number="8289" updated="2022-12-29T18:05:01Z">
  <state datetime="2022-07-05">REFERRED</state>
  <status>
    <introduced datetime="2022-07-05"/>
  </status>
  <introduced datetime="2022-07-05"/>
  <titles>
    <title type="display">Banning Misleading Drug Ads Act of 2022</title>
    <title type="short" as="introduced">Banning Misleading Drug Ads Act of 2022</title>
    <title type="official" as="introduced">To require the Secretary of Health and Human Services to promulgate a past due final rule with respect to direct-to-consumer prescription drug advertisements, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="S001209"/>
  <cosponsors>
    <cosponsor bioguide_id="A000378" joined="2022-07-05"/>
    <cosponsor bioguide_id="C001119" joined="2022-07-05"/>
    <cosponsor bioguide_id="N000147" joined="2022-10-31"/>
    <cosponsor bioguide_id="P000618" joined="2022-07-05"/>
    <cosponsor bioguide_id="W000826" joined="2022-07-05"/>
  </cosponsors>
  <actions>
    <action datetime="2022-07-05">
      <text>Introduced in House</text>
    </action>
    <action datetime="2022-07-05" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2022-10-21T20:39:59Z" status="Introduced in House">Banning Misleading Drug Ads Act of 2022

This bill finalizes a 2010 proposed rule from the Food and Drug Administration (FDA) regarding television and radio prescription drug advertisements if the FDA does not otherwise issue a final rule within 180 days of the bill's enactment. (The proposed rule specifies standards for major statements about a drug's side effects in television and radio advertisements.)</summary>
</bill>
